JACOBS LEVY EQUITY MANAGEMENT, INC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in PMVP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$223,042

-$432,395 QoQ

Shares Held

179,873

-65.7% QoQ

Ownership

0.337%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 69% Shared 0% None 31%

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $706,432,200 across 86 Biotechnology names. PMVP ranks #75 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	214,160	$165,468,582
2	INCY	Incyte Corp	1,717,978	$161,696,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	212,204	$70,211,937
4	HALO	Halozyme Therapeutics, Inc.	789,429	$51,020,796
5	RARE	Ultragenyx Pharmaceutical Inc.	1,431,071	$29,980,937
6	EXEL	Exelixis, Inc.	425,982	$18,270,367
7	AUPH	Aurinia Pharmaceuticals Inc.	1,097,189	$16,260,340
8	ARVN	Arvinas, Inc.	1,441,521	$15,280,122

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$223,042	179,873	-65.7%	Shares	Sole	2026-05-15
2025-12-31	$655,437	524,350	+663.6%	Shares	Sole	2026-02-13
2025-09-30	$96,135	68,668	-47.1%	Shares	Sole	2025-11-17
2025-03-31	$141,606	129,914	-75.9%	Shares	Sole	2025-05-15
2024-12-31	$815,238	539,893	-23.5%	Shares	Sole	2025-02-14
2024-09-30	$1,051,333	705,593	-9.4%	Shares	Sole	2024-11-14
2024-06-30	$1,262,020	779,025	-5.8%	Shares	Sole	2024-08-14
2024-03-31	$1,405,396	826,704	+92.4%	Shares	Sole	2024-05-15
2023-12-31	$1,331,890	429,642	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.